- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Curis Inc (CRIS)
Assess today's live Curis Inc (CRIS) share price, performance and insights using our live NASDAQ: CRIS stock exchange data.
Analyse the historical data and Curis Inc share price performance charts on this page. Our technical summary section provides analysis on Curis share price buy/sell indicators using real-time data (or discuss the Curis (CRIS) stock price today with other investors in the Curis NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CRIS share price (ISIN: US2312693094) to enhance your trading decisions with our free investment tools and resources.
What Is the Curis Inc Share Price Today?
The Curis share price today is 1.0400.
What Is the Stock Symbol for Curis Inc
The stock symbol (or 'ticker') for Curis Inc is "CRIS."
What Stock Exchange Does Curis Inc Trade On?
Curis Inc is listed and trades on the NASDAQ stock exchange.
Is Curis Inc a Good Stock to Buy?
Determining whether Curis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Curis Inc share price performance charts on this page. Our technical summary section provides analysis on Curis share price buy/sell indicators using real-time data (or discuss the Curis (CRIS) stock price today with other investors in the Curis NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CRIS share price (ISIN: US2312693094) to enhance your trading decisions with our free investment tools and resources.
What Is the Curis Inc Share Price Today?
The Curis share price today is 1.0400.
What Is the Stock Symbol for Curis Inc
The stock symbol (or 'ticker') for Curis Inc is "CRIS."
What Stock Exchange Does Curis Inc Trade On?
Curis Inc is listed and trades on the NASDAQ stock exchange.
Is Curis Inc a Good Stock to Buy?
Determining whether Curis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0300
1.0600
52 wk Range
1.0200
4.5000
CRIS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.03001.0600
52 wk Range
1.02004.5000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CRIS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
14.0000
Upside
+1,246.15%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Curis Company Profile
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes. The company’s pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma; CA-170, an oral, small-molecule antagonist designated as CA-170 that selectively targets PD-L1 and VISTA; and CA-327, an oral, small molecule, TIM3/PD-L1, which is a molecule antagonist of PD-L1 and TIM3. It has collaboration agreements with Genentech Inc., or Genentech and F. Hoffmann-La Roche Ltd, or Roche, for the commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway antagonist for the treatment of advanced basal cell carcinoma, or BCC; Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology; and also licensed three programs under the Aurigene collaboration, including emavusertib. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts.
Curis Inc Earnings Call Summary for Q3/2025
- Curis reported a Q3 2025 net loss of $7.7 million, improved from $10.1 million in Q3 2024, with R&D expenses decreasing to $6.4 million from $9.7 million, driving a 5.63% stock rise to $1.50.
- The company held $9.1 million in cash as of September 30, 2025, and plans to secure additional capital by year-end to support operations into 2026.
- Curis is advancing clinical trials in AML and CLL, with initial CLL study data expected at the ASH annual meeting in December 2026.
- CEO Jim Dentzer emphasized the strategy of enhancing treatment standards by integrating emavusertib into BTKI regimens, targeting rare diseases for substantial market opportunities.
Last Updated: 06/11/2025, 22:20
Read Full TranscriptCompare CRIS to Peers and Sector
Metrics to compare | CRIS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCRISPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −2.8x | −0.6x | |
PEG Ratio | −0.01 | 0.00 | 0.00 | |
Price/Book | −0.9x | 1.6x | 2.6x | |
Price / LTM Sales | 1.2x | 4.5x | 3.2x | |
Upside (Analyst Target) | - | 102.3% | 41.8% | |
Fair Value Upside | Unlock | 10.1% | 5.1% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 14.0000
(+1,246.15% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
-0.49 / -1.31
Revenue / Forecast
3.18M / --
People Also Watch
FAQ
What Is the Curis (CRIS) Share Price Today?
The live Curis share price today is 1.0400
What Stock Exchange Does Curis (CRIS) Trade On?
Curis is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Curis?
The stock symbol (also called a 'ticker') for Curis is "CRIS."
What Is the Current Curis Market Cap?
As of today, Curis market capitalisation is 13.45M.
What Is Curis's (CRIS) Earnings Per Share (TTM)?
The Curis EPS is currently -3.28 (Trailing Twelve Months).
Is CRIS a Buy or Sell From a Technical Analyst Perspective?
Based on today's Curis moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Curis Stock Split?
Curis has split 2 times. (See the CRIS stock split history page for full effective split date and price information.)
How Many Employees Does Curis Have?
Curis has 34 employees.
What is the current trading status of Curis (CRIS)?
As of 24 Dec 2025, Curis (CRIS) is trading at a price of 1.0400, with a previous close of 1.0300. The stock has fluctuated within a day range of 1.0300 to 1.0600, while its 52-week range spans from 1.0200 to 4.5000.
What Is Curis (CRIS) Price Target According to Analysts?
The average 12-month price target for Curis is USD14, with a high estimate of USD20 and a low estimate of USD5. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +1,246.15% Upside potential.
What Is the CRIS Premarket Price?
CRIS's last pre-market stock price is 1.0501. The pre-market share volume is 310.0000, and the stock has decreased by 0.0201, or 1.9500%.
What Is the CRIS After Hours Price?
CRIS's last after hours stock price is 1.0600, the stock has decreased by 0.0200, or 1.9200%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.